PNC Financial Services Group
HUMA icon

PNC Financial Services Group’s Humacyte HUMA Stock Holding History

PNC Financial Services Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Sell
3,448
-1,653
-32% -$1.53K ﹤0.01% 4588
2026
Q1 		$3.1K Buy
5,101
+2,003
+65% +$2.08K ﹤0.01% 4452
2025
Q4 		$2.98K Buy
3,098
+84
+3% +$119 ﹤0.01% 4425
2025
Q3 		$5.24K Sell
3,014
-314
-9% -$615 ﹤0.01% 4183
2025
Q2 		$6.96K Buy
3,328
+314
+10% +$603 ﹤0.01% 4011
2025
Q1 		$5.14K Buy
+3,014
New +$11.3K ﹤0.01% 4055
2022
Q1 		– Sell
-1,000
Closed -$7K – 4603
2021
Q4 		$7K Buy
+1,000
New +$9.89K ﹤0.01% 3876

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PNC Financial Services Group's HUMA Position: Q2 2026 in Review

PNC Financial Services Group reduced its Humacyte (HUMA) stake by 32% in Q2 2026, selling an estimated $1.53K and leaving 3,448 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #4588.

PNC Financial Services Group first reported a position in HUMA in Q4 2021 and has held it in 7 quarters since. The position peaked at $7K in Q4 2021. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • PNC Financial Services Group held 3,448 shares of Humacyte worth $2.69K as of Q2 2026.
  • PNC Financial Services Group sold 1,653 Humacyte shares in Q2 2026, an estimated $1.53K.
  • Humacyte made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4588 holding.
  • PNC Financial Services Group first reported a position in Humacyte in Q4 2021 and has held it in 7 quarters since.
  • PNC Financial Services Group's Humacyte position peaked at $7K in Q4 2021.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.